CHRISTOPHER KOCHIS: Open Payments
NPI 1609971696 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 18 payments from 9 companies in 2025. Trend: 2023 $774 · 2024 $507 · 2025 $668
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $221 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| ABBVIE INC. | 1 | $14 |
Products named: Auvelity, INGREZZA, CAPLYTA, FANAPT, REXULTI, AUSTEDO XR, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across CT — which companies pay providers there.
